Back
Repligen Stock Predictions
Sponsored
RGEN
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
RGEN
Repligen
Last Price:
$145.61
Seasonality Move:
17.5%
7 Day Trial
ALL ACCESS PASS
$
7
Repligen Stock Forecast
-
Over the next 52 weeks, Repligen has on average historically risen by 18% based on the past 38 years of stock performance.
-
Repligen has risen higher in 23 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 60.53%
-
Is Repligen Stock Undervalued?The current Repligen [RGEN] share price is $145.54. The Score for RGEN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
RGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Repligen Stock Go Up Next Year?
-
Over the next 52 weeks, Repligen has on average historically risen by 18% based on the past 38 years of stock performance.
Repligen Stock Rating
Sell
50
Repligen (RGEN)
is a Sell
Is Repligen overpriced?
-
Repligen has risen higher in 23 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 60.53%
Repligen Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
repligen.com
52-Week Data
52-Week High:
211.13
52-Week Low:
113.50
Prediction Charts
Market Cap:
8.2B
Price in USD:
145.54
Volume:
236.9K
Beta:
0.97
Technical Analysis
SMA50:
144.27
SMA100:
145.63
SMA200:
150.51
52-Wk Change:
-20.78%
Stock Predictions
-
Is Repligen stock public?Yes, Repligen is a publicly traded company.
-
What is the Repligen stock quote today?The Repligen stock price is 145.54 USD today.
-
How to buy Repligen stock online?You can buy Repligen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-9 | 150.35 | 154.72 | 156.94 | 149.97 |
Dec-10 | 154.71 | 151.94 | 156.75 | 150.56 |
Dec-11 | 153.54 | 155.25 | 157.25 | 152.34 |
Dec-12 | 153.13 | 155.99 | 157.91 | 153.13 |
Dec-13 | 156.54 | 156.41 | 158.07 | 151.50 |
Dec-16 | 155.37 | 160.92 | 161.24 | 155.37 |
Dec-17 | 159.94 | 158.14 | 160.65 | 157.24 |
Dec-18 | 158.23 | 147.34 | 160.05 | 146.45 |
Dec-19 | 147.26 | 146.54 | 149.32 | 143.91 |
Dec-20 | 145.70 | 144.47 | 150.56 | 143.96 |
Dec-23 | 144.05 | 145.65 | 146.49 | 141.20 |
Dec-24 | 144.31 | 146.95 | 147.86 | 142.53 |
Dec-26 | 144.89 | 145.78 | 147.99 | 143.03 |
Dec-27 | 145.22 | 145.54 | 146.49 | 142.52 |
Repligen Earnings
Repligen Earnings Report: Per Share Repligen Earnings Q1 Q2 Q3 and Q4 last year and next year.
Repligen Forecast Revenue Growth
Repligen Stock Analysis: Historical quarterly revenues per share for Repligen and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.19 per share.
* Repligen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.